Latest Health News

Tag: macclesfield

  • FDA lifts hold on AstraZeneca head and neck cancer trials

    —

    by

    creative
    in

    LONDON (Reuters) – U.S. officials have given a green light for two clinical trials testing AstraZeneca's cancer immunotherapy drug durvalumab in head and neck cancer to resume recruiting patients, lifting a hold imposed following cases of bleeding. The British drugmaker said on Tuesday that one of the late-stage Phase III trials had already re-opened for…

  • NHL-Highlights of Monday’s NHL games

    —

    by

    contributor
    in

    Highlights of Sunday’s National Hockey League games: Oilers 5, Blackhawks 0 After years of being tormented by their longtime nemesis from Chicago, the Edmonton Oilers gained a measure of revenge on Monday night with a 5-0 victory over the Blackhawks at Rogers Place Arena. Cam Talbot made 31 saves for the shutout as Edmonton beat…

  • Astrazeneca says Forxiga combination beats use of drug alone

    —

    by

    elegant
    in

    AstraZeneca said combining its Forxiga type-2 diabetes drug with older medicine Bydureon was more effective at controlling blood sugar levels than treatment with either drug on its own. In a late stage trial, Forxiga and Bydureon were tested on patients whose blood sugar levels could no longer be sufficiently kept in check under an initial…

  • Cost-cutting deal with unions key to VW’s recovery

    —

    by

    publisher
    in

    By Andreas Cremer BERLIN (Reuters) – Volkswagen's ability to agree a big cost-cutting plan with its powerful labor unions in the coming weeks could determine whether the German carmaker's shares make a full recovery from its emissions scandal. A year after it admitted using illegal software to rig diesel emissions tests, Volkswagen (VW) has still…

  • AstraZeneca taps gene pioneer Venter for huge drug-hunting sweep

    —

    by

    admin
    in

    By Ben Hirschler CAMBRIDGE, England (Reuters) – AstraZeneca, working with genome pioneer Craig Venter, is launching a massive gene hunt in the most comprehensive bet yet by a pharmaceutical firm on the potential of genetic variations to unlock routes to new medicines. The initiative, announced on Friday, involves sequencing up to 2 million human genomes…

  • AstraZeneca buys most of Acerta for $4 billion to add cancer drug

    —

    by

    elegant
    in

    By Ben Hirschler LONDON (Reuters) – AstraZeneca said on Thursday it had agreed to buy 55 percent stake of privately held biotech firm Acerta Pharma for $4 billion to give it access to a new kind of drug for fighting blood cancers. AstraZeneca will pay $2.5 billion upfront, with a further $1.5 billion paid either…